Prevalence and predictors of anti-SARS-CoV-2 serology in a highly vulnerable population of Rio de Janeiro: A population-based serosurvey.
Coelho LE, Luz PM, Pires DC, Jalil EM, Perazzo H, Torres TS, Cardoso SW, Peixoto EM, Nazer S, Massad E, Silveira MF, Barros FC, Vasconcelos ATR, Costa CAM, Amancio RT, Villela DAM, Pereira T, Goedert GT, Santos CVBD, Rodrigues NCP, Grinsztejn B, Veloso VG, Struchiner CJ.
Coelho LE, et al.
Lancet Reg Health Am. 2022 Nov;15:100338. doi: 10.1016/j.lana.2022.100338. Epub 2022 Jul 30.
Lancet Reg Health Am. 2022.
PMID: 35936224
Free PMC article.
We estimated the seroprevalence of anti-SARS-CoV-2 antibodies in a large favela complex in Rio de Janeiro, Brazil. METHODS: A population-based panel study was conducted in Complexo de Manguinhos (16 favelas) with a probabilistic sampling of participants aged 1 year …
We estimated the seroprevalence of anti-SARS-CoV-2 antibodies in a large favela complex in Rio de Janeiro, Brazil. METHODS: A populat …